Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: The AML99 trial from the Japanese childhood AML cooperative study group

Ichiro Tsukimoto, Akio Tawa, Keizo Horibe, Ken Tabuchi, Hisato Kigasawa, Masahiro Tsuchida, Hiromasa Yabe, Hideki Nakayama, Kazuko Kudo, Ryoji Kobayashi, Kazuko Hamamoto, Masue Imaizumi, Akira Morimoto, Shigeru Tsuchiya, Ryoji Hanada

Research output: Contribution to journalArticlepeer-review

187 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: The AML99 trial from the Japanese childhood AML cooperative study group'. Together they form a unique fingerprint.

Medicine & Life Sciences